IRIS
PELAIA, CORRADO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.292
EU - Europa 838
AS - Asia 693
SA - Sud America 94
AF - Africa 16
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.942
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.256
SG - Singapore 546
IT - Italia 451
DE - Germania 136
BR - Brasile 79
FI - Finlandia 62
GB - Regno Unito 53
CN - Cina 46
SE - Svezia 35
CA - Canada 25
HK - Hong Kong 24
NL - Olanda 23
IN - India 22
ES - Italia 14
FR - Francia 12
CZ - Repubblica Ceca 10
BD - Bangladesh 9
EG - Egitto 9
MX - Messico 7
PE - Perù 7
AT - Austria 6
IE - Irlanda 6
MY - Malesia 6
PL - Polonia 6
TR - Turchia 6
UA - Ucraina 6
AR - Argentina 5
AU - Australia 5
RU - Federazione Russa 5
EE - Estonia 4
IQ - Iraq 3
IR - Iran 3
JP - Giappone 3
MA - Marocco 3
PK - Pakistan 3
PT - Portogallo 3
SA - Arabia Saudita 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
GR - Grecia 2
ID - Indonesia 2
IL - Israele 2
KR - Corea 2
LT - Lituania 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
VN - Vietnam 2
ZA - Sudafrica 2
BB - Barbados 1
BN - Brunei Darussalam 1
CG - Congo 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
EU - Europa 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KI - Kiribati 1
KZ - Kazakistan 1
LB - Libano 1
PH - Filippine 1
RO - Romania 1
UY - Uruguay 1
Totale 2.942
Salva come PNG Salva come JPEG
Città #
Singapore 321
Chandler 170
Santa Clara 169
Munich 85
Milan 68
Princeton 66
Lawrence 65
Turku 45
Chicago 43
Ashburn 42
Catanzaro 42
Wilmington 41
London 39
Boardman 29
Hong Kong 22
Naples 22
Palermo 21
Rome 18
San Nicola Manfredi 18
Los Angeles 17
Des Moines 16
Helsinki 14
Florence 13
Bari 12
Redwood City 11
San Francisco 11
Troina 11
Olomouc 10
Brooklyn 9
Norwalk 9
Galbiate 8
Ottawa 8
Redmond 8
Alessandria 7
São Paulo 7
Castrovillari 6
Lima 6
Seattle 6
The Dalles 6
Amsterdam 5
Atlanta 5
Boston 5
Cosenza 5
Dublin 5
Hanover 5
Lamezia Terme 5
Padova 5
Warsaw 5
Ankara 4
Assago 4
Aversa 4
Beijing 4
Columbus 4
Indore 4
Messina 4
New York 4
Petaling Jaya 4
Phoenix 4
Providence 4
Rende 4
Rio de Janeiro 4
San Jose 4
Sohag 4
West Jordan 4
Afragola 3
Baltimore 3
Belo Horizonte 3
Brookline 3
Calgary 3
Cerreto Guidi 3
Gravina in Puglia 3
Houston 3
Mascalucia 3
Mexico City 3
Miami 3
Montreal 3
New Delhi 3
Pune 3
Raleigh 3
Taranto 3
Toronto 3
Turin 3
Xi'an 3
Al Mansurah 2
Ann Arbor 2
Baghdad 2
Bangkok 2
Birmingham 2
Bologna 2
Buffalo 2
Camden 2
Campbelltown 2
Catania 2
Charlotte 2
Chennai 2
Council Bluffs 2
Dallas 2
Denver 2
Dongguan 2
Fayetteville 2
Totale 1.721
Salva come PNG Salva come JPEG
Nome #
25-Hydroxy Vitamin D Detection Using Different Analytic Methods in Patients with Migraine 75
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 63
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 63
Benralizumab: From the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 54
Evaluation of a New Interface Combining High-Flow Nasal Cannula and CPAP 51
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 50
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial 49
MALDI MS-Based Investigations Targeting SARS-CoV-2 47
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 45
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy 42
Hexagonal Mesoporous Silica as a Rapid, Efficient and Versatile Tool for MALDI-TOF MS Sample Preparation in Clinical Peptidomics Analysis: A Pilot Study. 42
Effects of Sacubitril-Valsartan on Clinical, Echocardiographic, and Polygraphic Parameters in Patients Affected by Heart Failure With Reduced Ejection Fraction and Sleep Apnea 40
Comparisons of two diaphragm ultrasound-teaching programs: a multicenter randomized controlled educational study. 40
Association Between Sleep Apnea and Valvular Heart Diseases 40
Short term effect of sacubitril/valsartan on comprehensive geriatric assessment in chronic heart failure: a real life analysis 39
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 37
Uric acid and vascular damage in essential hypertension: Role of insulin resistance 37
Nasal polyposis: Insights in epithelial-mesenchymal transition and differentiation of polyp mesenchymal stem cells 37
Biologics in severe asthma 37
Recognizing, quantifying and managing patient-ventilator asynchrony in invasive and noninvasive ventilation. 36
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 36
Nurse led protocols for control of glycaemia in critically ill patients: A systematic review 35
Fluid Challenge During Anesthesia: A Systematic Review and Meta-analysis. 35
Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury 35
Current Practice of High Flow through Nasal Cannula in Exacerbated COPD Patients 35
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 35
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 34
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 33
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 32
Patient-ventilator asynchrony in adult critically ill patients 32
Assessment of cephalometric parameters and correlation with the severity of the obstructive sleep apnea syndrome 31
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 31
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 31
Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients 30
Gingival Crevicular Fluid Peptidome Profiling in Healthy and in Periodontal Diseases. 30
Asthma control during COVID-19 lockdown in patients with severe asthma under biological drug treatment 30
Device for Performing Spirometry in Total Laryngectomized Patients 29
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 29
Tezepelumab: A potential new biological therapy for severe refractory asthma 29
Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role 28
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis 28
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 28
Benefits of secretion clearance with high frequency percussive ventilation in tracheostomized critically ill patients: a pilot study 27
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 27
Mapping the SARS-CoV-2–host protein–protein interactome by affinity purification mass spectrometry and proximity-dependent biotin labeling: A rational and straightforward route to discover host-directed anti-SARS-CoV-2 therapeutics 27
What is the Role of Sex-Related Differences in the Effectiveness and Safety of Biological Drugs used in Patients' Severe Asthma? 26
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 25
Effects of continuous positive airway pressure on comprehensive geriatric assessment and cognitive function in elderly patients with obstructive sleep apnea syndrome 25
Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma 25
Predictors of renal function worsening in patients with chronic obstructive pulmonary disease (Copd): A multicenter observational study 25
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study 24
Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis 24
Real-World Evaluation of Dupilumab in the Long-Term Management of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps: A Focus on IL-4 and IL-13 Receptor Blockade 23
Intrinsic laryngeal lipoma treated with transoral Co2 laser microsurgery: An unusual case report 23
Primary mucosal melanoma presenting with a unilateral nasal obstruction of the left inferior turbinate 23
Severe Eosinophilic Asthma: from the Pathogenic role of Interleukin-5 to the Therapeutic Action of Mepolizumab. 22
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 22
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 21
Electrical impedance tomography during spontaneous breathing trials and after extubation in critically ill patients at high risk for extubation failure: a multicenter observational study. 21
Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma 21
Intraoperative protective ventilation in patients undergoing major neurosurgical interventions: a randomized clinical trial 21
Short-term evaluation of dupilumab effects in patients with severe asthma and nasal polyposis 21
MALDI MS-Based Investigations for SARS-CoV-2 Detection 21
Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic 20
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 20
Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives 20
Novel Biological Therapies for Severe Asthma Endotypes 19
Cost-Sensitive Models to Predict Risk of Cardiovascular Events in Patients with Chronic Heart Failure 19
Role of p38 mitogen-activated protein kinase in asthma and COPD: Pathogenic aspects and potential targeted therapies 19
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 18
Association between non-dipping blood pressure pattern and different glucometabolic profile during oral glucose tolerance test 17
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients? 17
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD 17
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study 16
Emerging biological treatments for asthma 16
Do Comorbidities Influence the Response to Biologics in Severe Asthma? 16
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 16
Complications during Veno-Venous Extracorporeal Membrane Oxygenation in COVID-19 and Non-COVID-19 Patients with Acute Respiratory Distress Syndrome 16
Mechanical ventilation in brain injured patients: seeing the forest for the trees 16
Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: results of a single-centre observational study 16
Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis 16
Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art 16
Monoclonal antibodies targeting alarmins: A new perspective for biological therapies of severe asthma 16
Oxygenation strategies during flexible bronchoscopy: a review of the literature 16
Switch from omalizumab to benralizumab in allergic patients with severe eosinophilic asthma: A real-life experience from Southern Italy 16
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting 15
New potential biomarkers for early chronic kidney disease diagnosis in patients with different glucose tolerance status 15
Dupilumab for the treatment of asthma 15
Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma 15
Benralizumab: From the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 15
Type 2 severe asthma: pathophysiology and treatment with biologics 14
Effects of High-Flow Nasal Cannula on Right Heart Dysfunction in Patients with Acute-on-Chronic Respiratory Failure and Pulmonary Hypertension 14
TSLP and HMGB1: Inflammatory Targets and Potential Biomarkers for Precision Medicine in Asthma and COPD 14
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study 14
Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life 14
Real-life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype 14
Phenotyping severe asthma: a rationale for biologic therapy 14
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis 13
Novel Biological Therapies for Severe Asthma Endotypes 13
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma 13
Totale 2.704
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.518
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021141 3 0 5 10 22 13 3 9 57 10 5 4
2021/2022233 5 5 29 31 7 8 22 40 29 22 34 1
2022/2023600 137 32 40 23 60 52 26 51 80 27 52 20
2023/2024380 67 45 32 27 12 75 6 17 6 25 24 44
2024/20251.637 166 18 26 32 191 215 109 49 165 53 257 356
2025/2026111 111 0 0 0 0 0 0 0 0 0 0 0
Totale 3.162